Oplawski Marcin, Średnicka Agata, Dutka Aleksandra, Tim Sabina, Mazur-Bialy Agnieszka
Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, Zlotej Jesieni 1, 31-826 Kraków, Poland.
Department of Gynecology and Obstretrics, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University, Gustawa Herlinga-Grudzińskiego 1, 30-705 Kraków, Poland.
J Clin Med. 2021 Nov 27;10(23):5579. doi: 10.3390/jcm10235579.
The incidence of endometrial cancer (EC), which coexists with such civilization diseases as diabetes, obesity or hypertension, is constantly increasing. Treatment includes surgery as well as brachytherapy, teletherapy, rarely chemotherapy or hormone therapy. Due to the good results of the treatment, the occurrence of side effects of therapy becomes a problem for the patients. One of the large groups of side effects includes the pelvic organ prolapse, urinary and fecal incontinence. The aim of this study was to present current knowledge on the occurrence of pelvic floor dysfunction in women treated for EC. A literature review was conducted in the PubMED and WoS databases, including articles on pelvic floor dysfunction in women with EC. PRISMA principles were followed in the research methodology. A total of 1361 publications were retrieved. Based on the inclusion and exclusion criteria, 24 papers were eligible for the review. Mostly retrospective studies based on different questionnaires were evaluated. No prospective studies were found in which, in addition to subjective assessment, clinical examination and objective assessment of urinary incontinence were used. Studies show a significant increase in the incidence of pelvic floor disorders, including urinary incontinence, after various forms of EC treatment. We believe that assessment of complications after endometrial cancer treatment is clinically relevant. The review emphasizes the importance of programming prospective studies to prevent and address these disorders at each stage of oncologic treatment.
子宫内膜癌(EC)与糖尿病、肥胖症或高血压等文明病并存,其发病率正在不断上升。治疗方法包括手术以及近距离放射治疗、远距放射治疗,很少采用化疗或激素治疗。由于治疗效果良好,治疗副作用的出现成为患者面临的一个问题。一大类副作用包括盆腔器官脱垂、尿失禁和大便失禁。本研究的目的是介绍目前关于接受EC治疗的女性盆底功能障碍发生情况的知识。在PubMED和WoS数据库中进行了文献综述,包括关于EC女性盆底功能障碍的文章。研究方法遵循PRISMA原则。共检索到1361篇出版物。根据纳入和排除标准,24篇论文符合综述要求。大多评估的是基于不同问卷的回顾性研究。未发现除主观评估外还使用临床检查和尿失禁客观评估的前瞻性研究。研究表明,在各种形式的EC治疗后,包括尿失禁在内的盆底疾病发病率显著增加。我们认为,评估子宫内膜癌治疗后的并发症具有临床相关性。该综述强调了规划前瞻性研究以在肿瘤治疗的每个阶段预防和解决这些疾病的重要性。